Your session is about to expire
← Back to Search
CBT vs ABC-I for Insomnia in PTSD
Study Summary
This trial will compare a new treatment, ABC-I, to Cognitive Behavioral Therapy for Insomnia (CBT-I) among Veterans with comorbid Post-Traumatic Stress Disorder (PTSD) and insomnia disorder. ABC-I has been shown to improve treatment adherence and the study objectives are to evaluate the benefits of ABC-I in reducing PTSD symptoms and improving insomnia symptoms and sleep quality.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You don't have a stable place to live, making it hard for us to keep track of important medical equipment.My insomnia symptoms have gone away before starting the trial.I do not have any unstable medical or mental health conditions.My sleep problems are due to a disorder related to my body's internal clock.You have used drugs recently or are in the process of recovering from drug use for less than 90 days.I am currently undergoing prolonged exposure therapy for PTSD.I am unable to give consent for myself.I am too sick to participate in study activities.I have severe sleep apnea that hasn't been treated.I am a Veteran, 18 or older, and live in the community.My sleep problems are due to restless legs syndrome.You have received care from VAGLAHS in the past year.I have trouble sleeping.I experience symptoms of PTSD.I experience symptoms of PTSD.I have trouble sleeping.
- Group 1: The ABC of Insomnia (Acceptance and the Behavioral Changes to
- Group 2: Cognitive-Behavioral Therapy for Insomnia
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the cap on patient enrollment for this clinical trial?
"Affirmative. According to clinicaltrials.gov, the trial was posted on September 1st 2022 and is currently searching for 400 participants from a single location. The data has been recently refreshed as of 9/2/2022."
Are applications still being accepted for involvement in this trial?
"Affirmative. According to the information available on clinicaltrials.gov, this medical trial is actively recruiting participants - having first been posted in September 1st 2022 and last updated two days later. 400 people are needed from a single clinic site for the study's completion."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger